MTHFR gene polymorphism and severe toxicity daring adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF) [1]

Annals of Oncology

Volumn 11, Issue 3, 2000, Pages 373-374

  Toffoli, G ^a   Veronesi, A ^a   Boiocchi, M ^a   Crivellari, D ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADJUVANT THERAPY; ADULT; AGED; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; LETTER; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC;

EID: 0033998678     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008337900349     Document Type: Letter

References (7)